Yuichiro Higashimoto

7.8k citations
96 papers · 6.5k indexed · 2 hit papers · h-index 36
Topics
Advanced Glycation End Products research (29 papers)Heme Oxygenase-1 and Carbon Monoxide (19 papers)Hemoglobin structure and function (14 papers)
Partner nations
JapanUnited StatesCanada

In The Last Decade

Yuichiro Higashimoto

93 papers receiving 6.4k citations

Hit Papers

PML regulates p53 acetylation and premature senescence in...200020262008201720002001200400600

Peers

Yuichiro Higashimoto
Comparison fields: 5 of 127
  • Molecular Biology 4.6k
  • Oncology 2.0k
  • Immunology 912
  • Cell Biology 793
  • Cancer Research 610
Replace Gordon C. Shore with:
Gordon C. Shore Canada
Jean‐Ehrland Ricci France
Solly Weiler United States
Grant Dewson Australia
Peter E. Czabotar Australia
Lisa Bouchier‐Hayes United States
Hans Kristian Lorenzo France
Markus Loeffler Germany
Roberto Bei Italy
Yuichiro Higashimoto relative to Gordon C. Shore Canada Gordon C. Shore's profile →
Citations per field
00.5×1.5×2.5×
Gordon C. Shore · 1×
Citations per year

Countries citing papers authored by Yuichiro Higashimoto

Since Specialization
Citations

This map shows the geographic impact of Yuichiro Higashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Higashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Higashimoto more than expected).

Fields of papers citing papers by Yuichiro Higashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Higashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Higashimoto. The network helps show where Yuichiro Higashimoto may publish in the future.

Co-authorship network of co-authors of Yuichiro Higashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Higashimoto. A scholar is included among the top collaborators of Yuichiro Higashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Higashimoto. Yuichiro Higashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 4
3 6
4 8
5 5
6 1
7 3
8 52
9 29
10 23
11 21
12 108
13 20
14 7
15 55
16
p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.
229
17 203
18 277
19 60
20 22

About Yuichiro Higashimoto

Yuichiro Higashimoto is a scholar working on Clinical Biochemistry, Nephrology and Cell Biology, having authored 96 papers that have together received 6.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (29 papers), Heme Oxygenase-1 and Carbon Monoxide (19 papers) and Hemoglobin structure and function (14 papers). The work is most often cited by research in Oncology (2.0k citations), Clinical Biochemistry (471 citations) and Molecular Biology (4.6k citations). Yuichiro Higashimoto has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Ettore Appella, Shinichi Saito, Takanori Matsui, Sho‐ichi Yamagishi, Carl W. Anderson, Albert J. Fornace, Masato Noguchi, Kazuyasu Sakaguchi, Hiroshi Sakamoto and Dmitry V. Bulavin. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026